These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19168396)

  • 1. Evidence regarding clinical use of microvolt T-wave alternans.
    Hohnloser SH; Ikeda T; Cohen RJ
    Heart Rhythm; 2009 Mar; 6(3 Suppl):S36-44. PubMed ID: 19168396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death.
    Amit G; Rosenbaum DS; Super DM; Costantini O
    Heart Rhythm; 2010 Jun; 7(6):763-8. PubMed ID: 20156592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis.
    Gupta A; Hoang DD; Karliner L; Tice JA; Heidenreich P; Wang PJ; Turakhia MP
    Am Heart J; 2012 Mar; 163(3):354-64. PubMed ID: 22424005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.
    Merchant FM; Ikeda T; Pedretti RF; Salerno-Uriarte JA; Chow T; Chan PS; Bartone C; Hohnloser SH; Cohen RJ; Armoundas AA
    Heart Rhythm; 2012 Aug; 9(8):1256-64.e2. PubMed ID: 22406384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
    Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans.
    Sandhu RK; Costantini O; Cummings JE; Poelzing S; Rosenbaum DS; Quan KJ
    Heart Rhythm; 2008 Jul; 5(7):1003-8. PubMed ID: 18598955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Barbosa MPT; da Costa Rocha MO; Neto ES; Brandão FV; Lombardi F; Ribeiro ALP
    Int J Cardiol; 2016 Nov; 222():80-85. PubMed ID: 27467316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
    Daniłowicz-Szymanowicz L; Kaufmann D; Rozwadowska K; Kempa M; Lewicka E; Raczak G
    PLoS One; 2018; 13(5):e0196812. PubMed ID: 29723261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
    Armoundas AA; Hohnloser SH; Ikeda T; Cohen RJ
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):522-8. PubMed ID: 16186850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
    Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microvolt T wave alternans as a predictor for sudden cardiac death].
    Tanno K; Katagiri T
    Nihon Rinsho; 2002 Jul; 60(7):1324-33. PubMed ID: 12136610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Use of Microvolt T-Wave Alternans Testing to Guide Primary Prevention Implantable Cardioverter Defibrillator Therapy.
    Merchant FM; Salerno-Uriarte JA; Caravati F; Falcone S; Molon G; Marangoni D; Raczak G; Danilowicz-Szymanowicz L; Pedretti RF; Sarzi Braga S; Ikeda T; Calo L; Martino A; Erciyes D; Piancastelli M; Maury P; Cohen RJ; Armoundas AA
    Circ J; 2015; 79(9):1912-9. PubMed ID: 26073692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.